Greenlight laser in benign prostatic hyperplasia: Turning green into gold

Current Opinion in Urology

Volumn 18, Issue 1, 2008, Pages 46-49

  Alivizatos, Gerasimos ^a   Skolarikos, Andreas ^a  

^a SISMANOGLIO HOSPITAL   (Greece)

Author keywords

Benign prostatic hyperplasia; Greenlight laser; Photovaporization of the prostate; Potassium titanyl phosphate laser; Prostatectomy

Indexed keywords

COST EFFECTIVENESS ANALYSIS; GREENLIGHT LASER; HUMAN; PHOTOSELECTIVE VAPORIZATION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; REVIEW; SURGICAL TECHNIQUE; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; VAPORIZATION;

HUMANS; LASERS, SOLID-STATE; MALE; PROSTATECTOMY; PROSTATIC HYPERPLASIA; URINARY BLADDER NECK OBSTRUCTION;

EID: 37349109608     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e3282f0d63b     Document Type: Review

References (27)

1. Mebust W, Holtgrewe H, Cockett A, Peters P, Writing Committee, the American Urological Association. Transurethral prostatectomy: Immediate and postoperative complications. Cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 1989; 141:243-247.
2. Malek R, Kuntzman R, Barrett D. Photoselective potassium-titanyl- phosphate laser vaporization of the benign obstructive prostate: Observations on long-term outcomes. J Urol 2005; 174:1344-1348.
3. Bouchier D, Anderson P, Van Appledorn S, et al. KTP laser versus transurethral resection: Early results of a randomized trial. J Endourol 2006; 20:580-585.
4. Bachmann A, Ruszat R, Wyler S, et al. Photoselective vaporization of the prostate: the basal experience after 108 procedures. Eur Urol 2005; 47:798-804.
5. Te A, Malloy TR, Stein BS, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12 month results from the first United States multicenter prospective study. J Urol 2004; 172:1404-1408.
6. Sarica K, Alkan E, Luleci H, Tasci AI. Photoselective vaporization of the enlarged prostate with KTP laser: long-term results in 240 patients. J Endourol 2005; 19:1199-1202.
7. Sandhu JS, Ng C, Vanderbrink BA, et al. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 2004; 64:1155-1159.
8. Ruszat R, Wyler S, Forster T, et al. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 2006; 18 Aug [Epub ahead of print].
9. Chandrasekera S, Muir G. Potassium titanyl phosphate laser prostatectomy: a review. Curr Opin Urol 2007; 17:22-26. This is a systematic review of all the important papers dealing with all aspects of the PVP procedure.
10. Alivizatos G, Skolarikos A. Photoselective vaporization of the prostate. Review of cost implementation to BPH treatment. Prostate Cancer Prostatic Dis 2007; 10:S15-S20. The authors provide a summary of all the information found in the literature dealing with the financial implications of the PVP procedure.
11. Ruszat R, Susler T, Seifert H, et al. Photoselective vaporization (PVP) vs transurethral electroresection of the prostate (TURP): A comparative cost analysis. EAU Congress Paris Abstract No 996. Eur Urol Suppl 2006; 5:271.
12. Stovsky MD, Griffiths RI, Duff SB. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia. J Urol 2006; 176:1500-1506. A comparison of photoselective vaporization of the prostate to alternative treatment options showed that PVP is clinically efficacious and cost effective for the treatment of BPH.
13. Reich O, Bachmann A, Siebels M, et al. High-power (80W) potassium-titanyl-phosphate photoselective laser vaporization of the prostate in 66 high risk patients. J Urol 2005; 173:158-160.
14. Hamann MF, Wild C, Seif C, et al. Functional outcome after laser vaporization of the prostate with the KTP laser. Urologe A 2007; 46:521-527.
15. Verger-Kuhnke AB, Reuter MA, Epple W, et al. Photoselective vaporization with the 80-watt KTP-laser and low hydraulic pressure TURP in the treatment of BPH: our experience with 230 cases. Arch Esp Urol 2007; 60:167-177.
16. Kuromatsu I, Imamura T, Sugimura Y. Photoselective vaporization of the prostate (PVP) using 80 watt high power potassium-titanyl phosphate (KTP) laser for benign prostatic hyperplasia: the first fifty seven patients in Japan. Nippon Hinyokika Gakkai Zasshi 2006; 97:815-822.
17. Bachmann A, Ruszat R. The KTP (greenlight) laser principles and experiences. Minim Invasive Ther Allied Technol 2007; 16:5-10.
18. Ahmed HU, Thwaini A, Shergill IS, et al. Greenlight prostatectomy: a challenge to the gold standard? A review of KTP photoselective vaporization of the prostate. Surg Laparosc Endosc Percutan Tech 2007; 17:156-163.
19. Te AE, Malloy TR, Stein BS, et al. Impact of prostate specific antigen and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int 2006; 97:1229-1233. This was the first study dealing with predictors of efficacy of the PVP laser treatment.
20. Rajbabu K, Chandrasekara SK, Barber NJ, et al. Photoselective vaporization of the prostate with the potassium titanyl phosphate laser in men with prostates of >100 ml. BJU Int 2007; 19 May [Epub ahead of print].
21. Barber NJ, Zhu G, Donohue JF, et al. Use of expired breath ethanol measurements in evaluation of irrigant absorption during high power potassium titanyl phosphate laser vaporization of prostate. Urology 2006; 67:80-83.
22. Rajbabu K, Dudderidge T, Barber NJ, et al. Evaluation of ideal irrigation fluid in Greenlight photoselective vaporization of the prostate. Prostate Cancer Prostatic Dis 2007; 10:101-103.
23. Van Exel N, Koopmanschap M, McDonnell J, et al. Medical consumption and costs during a one year follow up of patients with LUTS suggestive of BPH in six European Countries: Report of the TRIUMPH study. Eur Urol 2006; 49:92-102.
24. De la Rosette JJ, Kortmann B, Rossi C, et al. Long term risk of re-treatment of patients using alpha-blockers for lower urinary tract symptoms. J Urol 2002; 167:1734-1739.
25. Vela-Navarrete R, Gonzalez-Enguita C, Garcia-Cardoso J, et al. The impact of medical therapy on surgery for benign prostatic hyperplasia: A study comparing changes in a decade (1992-2002). BJU Int 2005; 1045-1048.
26. De la Rosette J, Alivizatos G. Lasers for the treatment of bladder outflow obstruction: are they challenging conventional treatment modalities? Eur Urol 2006; 50:418-420.
27. Gomez Sancha F, Bachmann A, Choi BB, et al. Photoselective vaporization of the prostate (GreenLight PV): lessons learnt after 3500 procedures. Prostate Cancer Prostatic Dis 2007; 10 July [Epub ahead of print].